This inventor holds 1 USPTO granted patent. Top assignee: Thermo Fisher Scientific Baltics Uab. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Remigijus Skirgalia: Innovator in Restriction Endonucleases
Introduction
Remigijus Skirgalia is a notable inventor based in Vilnius, Lithuania. He has made significant contributions to the field of molecular biology, particularly in the development of restriction endonucleases. His work has implications for genetic research and biotechnology.
Latest Patents
Skirgalia holds a patent for a restriction endonuclease with a recognition sequence of 5'-TCGA-3′. This innovative enzyme is sensitive to the presence of a modified cytosine residue in its recognition sequence. The patent also discloses methods and kits that utilize this restriction endonuclease, enhancing its practical applications in various scientific fields.
Career Highlights
Currently, Remigijus Skirgalia is associated with Thermo Fisher Scientific Baltics UAB, where he continues to advance his research and development efforts. His expertise in molecular biology has positioned him as a valuable asset in the scientific community.
Collaborations
Skirgalia has collaborated with esteemed colleagues, including Renata Rimseliene and Arvydas Lubys. These partnerships have fostered a collaborative environment that promotes innovation and scientific discovery.
Conclusion
Remigijus Skirgalia's contributions to the field of restriction endonucleases exemplify the impact of innovative research in biotechnology. His work not only advances scientific knowledge but also paves the way for future developments in genetic engineering.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile